Soni Medicare Ltd

Soni Medicare Ltd has announced the closure of its trading window for all directors, officers, designated persons, and their immediate relatives. This closure is effective from July 1, 2026, and will remain in effect until 48 hours after the declaration of the audited financial results for the quarter ending June 30, 2026. The specific date for the board meeting to approve these results will be communicated separately. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, to prevent potential insider trading activities.

Soni Medicare Ltd's audited financial results for the year ended March 31, 2026, reveal a net loss of ₹270.80 lakhs. The company's total income stood at ₹2,624.54 lakhs, while total expenses amounted to ₹2,888.64 lakhs. The Board of Directors approved these results in their meeting held on May 30, 2026. The company operates in a single reportable segment, 'Healthcare Facilities'.

Soni Medicare Ltd has declared its audited financial results for the quarter and financial year ended March 31, 2026. The company reported a net loss of ₹270.8 lakhs for the year ended March 31, 2026, compared to a net loss of ₹18.64 lakhs in the previous year. Revenue from operations stood at ₹2,470.85 lakhs for the year ended March 31, 2026, compared to ₹2,983.82 lakhs in the previous year.

Soni Medicare Ltd has announced a Board of Directors meeting scheduled for May 30, 2026, to consider and approve the audited standalone financial statements for the year ended March 31, 2026, along with the auditor's report. The board will also consider and approve the re-appointment of the Internal Auditor for the F.Y. 2026-27. The trading window for dealing in the company's securities remains closed until 48 hours after the announcement of the financial results.

Soni Medicare Ltd has announced the closure of the trading window for all Directors, Officers, Designated Persons and their immediate relatives, as per the SEBI (Prohibition of Insider Trading) Regulations, 2015. The closure will be in effect from 01% April, 2026 till 48 hours after the declaration of the audited financial results for the quarter ended on 31 March 2026. The date of the Board Meeting to consider and take on record the audited financial results will be intimated separately.

Soni Medicare Ltd, a company operating in the healthcare and skill development sectors, has reported its financial results for the quarter and nine months ended 31st December 2025. The company's revenue for the nine-month period stood at INR 1,966.34 crore, representing a growth of 1.57% compared to the same period last year. The profit before tax for the period was INR 48.29 crore, down by 22.17% year-on-year. The company's net profit for the period was INR 22.17 crore.

Soni Medicare Ltd has appointed Mr. Lavi Kumar Mutha as Additional Non-Executive Independent Director with effect from 14th February 2026. Mr. Mutha is an MBA and B.Com graduate with strong expertise in healthcare administration, financial management, and strategic planning. He is not related to any of the Directors/Key Managerial Personnel of the Company and is not debarred from holding office of Directors by any order passed by Securities and Exchange Board of India or any other authority. His appointment is subject to approval of the Shareholder in the ensuing AGM.

Soni Medicare Ltd. announced the approval of its un-audited financial results for the quarter and nine months ended on 31st December, 2025. The company's board of directors took this decision in a meeting held on 14th February, 2026. The meeting also saw the appointment of Mr. Lavi Kumar Mutha as an Additional Director and Non-executive Independent Director for a term of 5 consecutive years, subject to the approval of the company's members. The review report by 'A(W TAMBI ASHOK & ASSOCIATES YV CHARTERED ACCOUNTANTS LIMITED' concluded that the financial results were prepared in accordance with the Indian Accounting Standard 34 and other applicable accounting principles.

Soni Medicare Ltd has scheduled a Board of Directors meeting on February 14, 2026, to consider and approve the unaudited Financial Results for the quarter ended on December 31, 2025. The meeting will be held at the company's registered office in Jaipur, Rajasthan. The trading window for dealing in securities of the company has been closed for all designated persons and their immediate relatives since January 1, 2026, and will remain closed till 48 hours after the announcement of the financial results.

In a recent board meeting, Soni Medicare Ltd. considered and approved new borrowing facilities from three banks: a borrowing facility for a car loan from any suitable bank, an unsecured borrowing facility from TATA Capital, and an unsecured borrowing facility from Godrej Capital Limited. The board authorized the directors to execute the necessary documents, deeds, and agreements for these borrowing facilities.